Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.345 AUD | -2.82% | +1.47% | +68.29% |
May. 01 | Dimerix Secures Pediatric Plan Approval in the UK for Kidney Disease Medication | MT |
Apr. 22 | Dimerix Posts AU$35.2 Million Cash, AU$3.3 Million Operating Cash Outflows for March Quarter | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+68.29% | 130M | |
+41.79% | 54.04B | |
-0.56% | 41.92B | |
+47.87% | 41.96B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+24.91% | 12.19B | |
+29.60% | 12.28B |
- Stock Market
- Equities
- DXB Stock
- News Dimerix Limited
- Dimerix Secures Pediatric Plan Approval in the UK for Kidney Disease Medication